Personalized Medicine Market Will Grow at Highest Pace Owing To Growing Demand for Targeted Therapies
Personalized Medicine Market Personalized medicine involves tailoring medical treatment to an individual based on their predicted response. It uses molecular diagnostic tools to classify individuals into distinct risk categories or other classifications that determine disease predisposition or likely response to a specific treatment. Personalized medicine aims to improve the safety and efficacy of pharmaceutical drugs by targeting specific patient populations who are most likely to benefit. The increasing adoption of targeted therapies and companion diagnostics driven by advances in molecular technologies is driving the growth of the personalized medicine market. The Global Personalized Medicine Market is estimated to be valued at US$ 81.33 Billion in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the Personalized Medicine Market are Precision Biologics, Danaher Corporation, Abbott, Illumina, I...